📰 Nasdaq Rdnt News
Nasdaq Rdnt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Rdnt. Real-time updates on events, politics, business and more.
March 25, 2024
RadNet (NASDAQ:RDNT – Free Report) had its target price boosted by Jefferies Financial Group from $47.00 to $58.00 in a research report sent to investors on Friday morning, Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. A number of other equities research analysts have also weighed in on […]
February 20, 2024
Paradigm Capital Management Inc. NY trimmed its stake in shares of RadNet, Inc. (NASDAQ:RDNT – Free Report) by 7.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 50,900 shares of the medical research company’s stock after selling 4,300 shares during the quarter. Paradigm […]
February 20, 2024
Paradigm Capital Management Inc. NY reduced its position in RadNet, Inc. (NASDAQ:RDNT – Free Report) by 7.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 50,900 shares of the medical research company’s stock after selling 4,300 shares during the period. […]
January 13, 2024
Stratos Wealth Partners LTD. purchased a new stake in RadNet, Inc. (NASDAQ:RDNT – Free Report) in the 3rd quarter, HoldingsChannel.com reports. The fund purchased 8,409 shares of the medical research company’s stock, valued at approximately $237,000. Several other institutional investors and hedge funds have also recently bought and sold shares of RDNT. State Board of […]
December 10, 2023
RadNet, Inc. (NASDAQ:RDNT – Get Free Report) EVP Michael N. Murdock sold 10,115 shares of the stock in a transaction that occurred on Tuesday, December 5th. The stock was sold at an average price of $35.02, for a total transaction of $354,227.30. Following the completion of the transaction, the executive vice president now owns 68,432 […]
December 8, 2023
RadNet, Inc. (NASDAQ:RDNT – Get Free Report) EVP Michael N. Murdock sold 10,115 shares of the company’s stock in a transaction that occurred on Tuesday, December 5th. The stock was sold at an average price of $35.02, for a total transaction of $354,227.30. Following the sale, the executive vice president now owns 68,432 shares in […]
November 27, 2023
Citigroup Inc. lifted its position in shares of RadNet, Inc. (NASDAQ:RDNT – Free Report) by 18.7% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 122,991 shares of the medical research company’s stock after buying an additional 19,402 shares during the quarter. Citigroup Inc. owned […]
November 17, 2023
Beverly Hills Private Wealth LLC purchased a new position in shares of RadNet, Inc. (NASDAQ:RDNT – Free Report) during the second quarter, Holdings Channel.com reports. The institutional investor purchased 7,000 shares of the medical research company’s stock, valued at approximately $232,000. A number of other institutional investors have also recently bought and sold shares of […]
November 9, 2023
RadNet (NASDAQ:RDNT – Get Free Report) released its earnings results on Wednesday. The medical research company reported $0.14 EPS for the quarter, topping analysts’ consensus estimates of $0.06 by $0.08, Briefing.com reports. RadNet had a negative net margin of 0.84% and a positive return on equity of 3.98%. The business had revenue of $401.97 million […]
October 21, 2023
StockNews.com lowered shares of RadNet (NASDAQ:RDNT – Free Report) from a hold rating to a sell rating in a research note issued to investors on Tuesday. Separately, Truist Financial started coverage on shares of RadNet in a report on Thursday, August 31st. They set a buy rating and a $40.00 price objective on the stock. […]